🔎 Trials Near Me

Почетна › Висок крвен притисок › Arizona

Клинички испитувања за Висок крвен притисок во Arizona

12 студии за Висок крвен притисок бараат учесници на локации во Arizona.

Градови во Arizona

Официјален текст на студијата (англиски)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, Tucson
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT07142356

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

  • Banner - University Medical Center Tucson, Tucson
Се регрутира
Возраст од 18 до 85 · Сите полови · Ажурирано 1.10.2026 · NCT07214376

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Pima Heart, Tucson
  • Eclipse Clinical Research, Tucson
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Arizona Clinical Trials - Chandler, Chandler
  • Elite Clinical Studies, Phoenix
  • Clinical Research Institute of Arizona, LLC, Sun City West
  • и уште 3
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07064473

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Care Access - 801 South Power Road, Mesa, Mesa
  • Absolute Clinical Research, Phoenix
  • Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Surprise
  • Research Site, Tucson
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • HonorHealth, Scottsdale
Се регрутира
Возраст од 22 до 75 · Сите полови · Ажурирано 24.9.2026 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Chandler
  • Clinical Trial Site, Gilbert
  • Clinical Trial Site, Mesa
  • и уште 8
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT07181109

Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH

  • Banner University Medical Center South, Tucson
  • UAHS Center for Sleep, Circadian, & Neuroscience Research Department of Medicine, University of Arizona, Tucson
Се регрутираДобредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT07799961

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Phoenix
  • Vanda Investigative Site, Tempe
  • Vanda Investigative Site, Tucson
Се регрутираФаза 2
Возраст од 18 до 65 · Сите полови · Ажурирано 27.2.2026 · NCT07090161

bpMedManage: Digital Technology to Support Adherence to Hypertension Medications

  • University of Arizona, Tucson
Се регрутира
Возраст 60 и постари · Сите полови · Ажурирано 15.10.2025 · NCT06307574

CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona

  • School of Informatics Computing and Cyber Systems, Flagstaff
  • Northern Arizona University, Flagstaff
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 5.6.2025 · NCT06487637

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.